FAF‐Drugs4: free ADME‐tox filtering computations for chemical biology and early stages drug discovery

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Bioinform.

• Publication date

  2017-11-15

• Fields of study

  Biology, Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1093/bioinformatics/btx491PMID 28961788
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors

  2017cited by this paper
• Molecular inflation, attrition and the rule of five.

  2016cited by this paper
• Computational Chemistry in the Pharmaceutical Industry: From Childhood to Adolescence

  2015cited by this paper
• FAF-Drugs3: a web server for compound property calculation and chemical library design

  2015cited by this paper
• Chemical predictive modelling to improve compound quality

  2013cited by this paper
• Quantifying the chemical beauty of drugs.

  2012cited by this paper
• The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections

  2011cited by this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cited by this paper
• Generation of a set of simple, interpretable ADMET rules of thumb.

  2008cited by this paper
• The influence of drug-like concepts on decision-making in medicinal chemistry

  2007cited by this paper
• Computation of Octanol-Water Partition Coefficients by Guiding an Additive Model with Knowledge

  2007cited by this paper
• FAF-Drugs: free ADME/tox filtering of compound collections

  2006cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics

  1989influential reference
• Atomic physicochemical parameters for three-dimensional-structure-directed quantitative structure-activity relationships. 2. Modeling dispersive and hydrophobic interactions

  1987influential reference
• BIOINFORMATICS ORIGINAL PAPER

  year unknowncited by this paper

• Stress-Induced Plant Specialized Metabolism: Signaling, Multi-Omics Integration, and Plant-Derived Antimicrobial Metabolites to Combat Antimicrobial Resistance

  2026cites this paper
• Targeting the VP24-Karyopherin-α Interface With Phytocompounds: A Structure-Based Molecular Screening and Dynamic Simulation Approach to Rescue Immune Responses Against Ebola Virus

  2026cites this paper
• Cell wall target fragment discovery using a low-cost, minimal fragment library.

  2026cites this paper
• Unveiling the Anti-Dengue Potential of Cedrus deodar Bark Extract Through the Network Pharmacology, In Silico, In Vivo, and In Vitro Strategies

  2026cites this paper
• Restoring Ovarian Function in PCOS: Ethanol Extract of Alocasia indica Tuber Attenuates Hormonal Imbalance, Oxidative Stress, and Cystic Follicles in a letrozole-induced rat model

  2026cites this paper
• Pharmacokinetics, quantum chemistry, and molecular modeling analysis of six potential drug candidates for Chagas disease: posaconazole, K777, phenarimol derivative, BZTS, isoxazole analog, and derivative of 4-arylaminonoline-3-carbonitrile.

  2026cites this paper
• Sanguinarine alleviates pendimethalin-induced neurotoxicity via regulating microglial and neuroinflammatory pathways: An interplay of oxidative stress, apoptosis and microglial polarization.

  2026cites this paper
• Comparative pharmacoinformatic and quantum descriptor insights from BFM/GBTLI guidelines to phase I/II compounds for acute lymphoblastic leukemia (ALL)

  2026cites this paper
• Targeting TUBG1 in RB1‐negative tumors

  2025cites this paper
• Synthesis, computational profiling, and anti-inflammatory potential of a thymol-mefenamic acid hybrid derivative

  2025cites this paper
• Prediction of Pharmacokinetics of Valeric Acid: Alternative Tool to Minimize Animal Studies.

  2025cites this paper
• Identification of Novel Fourth-Generation Allosteric Inhibitors Targeting Inactive State of EGFR T790M/L858R/C797S and T790M/L858R Mutations: A Combined Machine Learning and Molecular Dynamics Approach.

  2025cites this paper
• New strategies to enhance the efficiency and precision of drug discovery

  2025cites this paper
• Toxicological insights and safety considerations of vorasidenib in grade 2 astrocytoma and oligodendroglioma

  2025cites this paper
• Chemical Targeting of the ATXN1 aa99–163 Interaction Site Suppresses polyQ-Expanded Protein Dimerization

  2025cites this paper
• Advancing the development of deep learning and machine learning models for oral drugs through diverse descriptor classes: a focus on pharmacokinetic parameters (Vdss and PPB).

  2025cites this paper
• Identifying drug targets and evaluating KLK3-targeted inhibitors for prostate cancer using in-silico and in-vitro approaches

  2025influential citation
• Therapeutic Evaluation of Gut Microbiota-Derived Metabolites (GMDM) through Computational Approaches: A Narrative Review

  2025cites this paper
• Structure-Based Discovery of Orthosteric Non-Peptide GLP-1R Agonists via Integrated Virtual Screening and Molecular Dynamics

  2025cites this paper
• Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin

  2025cites this paper
• Pharmacological Evaluation of active compounds in papaya associated with thrombocytopenia inhibition in dengue patients through in silico approaches

  2025cites this paper
• Structure-Based Design of Small-Molecule Inhibitors of Human Interleukin-6

  2025cites this paper
• Molecular Screening and Free Energy Calculations‐Based Exploration of Medicinal Phytocompounds Chemical Space to Abrogate G9R‐E4R Complex from Monkeypox: A Current Global Health Threat

  2025cites this paper
• Innovative strategy for chitosan nanoparticles biosynthesis using Gelidium amansii, statistical optimization, characterization, cytotoxicity and molecular docking against hepatocellular carcinoma.

  2025cites this paper
• Structural bioinformatics for rational drug design

  2025cites this paper
• Dual Inference Routes for Natural Language Hypothesis Generation in Multimodal Drug Discovery: An Early Experimentation Study

  2025cites this paper
• Dimethoxybenzohomoadamantane-based soluble epoxide hydrolase inhibitors: in vivo efficacy in a murine model of chemotherapy-induced neuropathic pain

  2025influential citation
• Inibidores enzimáticos derivados da Catharanthus roseus na prospecção de novos medicamentos para o combate à COVID-19: ancoragem molecular e investigações ADMET

  2025cites this paper
• Discovery of N-Hydroxypyridinedione-Based Inhibitors of HBV RNase H: Design, Synthesis, and Extended SAR Studies

  2025cites this paper
• Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction

  2025influential citation
• Apigenin derivatives as promising norovirus RdRp inhibitors: insights from in silico docking and molecular dynamics studies

  2025cites this paper
• Structure, Function, and Inhibition of Adenylosuccinate Lyase (ADSL) from Mycobacterium tuberculosis.

  2025cites this paper
• Holistic concept guided quality control of traditional Chinese medicines for optimizing bioavailability

  2025cites this paper
• Artificial intelligence in drug development for delirium and Alzheimer’s disease

  2025influential citation
• Screening of medicinal phytocompounds with structure-based approaches to target key hotspot residues in tyrosyl-DNA phosphodiesterase 1: augmenting sensitivity of cancer cells to topoisomerase I inhibitors

  2025cites this paper
• In silico and in vitro evaluation of N-heterocyclic derivatives as antimicrobials: ADMET analysis, SAR, and molecular docking

  2025cites this paper
• MolPILE - large-scale, diverse dataset for molecular representation learning

  2025cites this paper
• Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene Regulation

  2025cites this paper
• In-silico evaluation of Cassia occidentalis phytochemicals for Plasmodium falciparum plasmepsin V inhibition: Revealing antimalarial potential

  2025cites this paper
• Computer‐Aided Algorithmic Approaches to Drug Development for Multi‐Mutant HIV‐1 Reverse Transcriptase

  2025cites this paper
• Targeting TetR-family transcription regulators for combating tetracycline resistance in resilient Acinetobacter baumannii: in silico identification of potent inhibitors

  2025cites this paper
• In Silico ADME Methods Used in the Evaluation of Natural Products

  2025cites this paper
• N-Hydroxypiridinedione: A Privileged Heterocycle for Targeting the HBV RNase H

  2024cites this paper
• Uncovering the Role of Anmeidan against Atherosclerosis from Integrated Network Pharmacology and Pharmacological Experiments.

  2024cites this paper
• ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery

  2024cites this paper
• A robust computational quest: Discovering potential hits to improve the treatment of pyrazinamide‐resistant Mycobacterium tuberculosis

  2024cites this paper
• Preliminary insight on diarylpentanoids as potential antimalarials: In silico, in vitro pLDH and in vivo zebrafish toxicity assessment

  2024cites this paper
• Structure-activity relationship of pharmacophores and toxicophores: the need for clinical strategy

  2024cites this paper
• In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells

  2024cites this paper
• An Integrated Comprehensive Peptidomics and In Silico Analysis of Bioactive Peptide-Rich Milk Fermented by Three Autochthonous Cocci Strains

  2024cites this paper
• In Silico Drug Repurposing Uncovered the Antiviral Potential of the Antiparasitic Drug Oxibendazole Against the Chikungunya Virus

  2024cites this paper
• Exploring the natural products chemical space to abrogate the F3L-dsRNA interface of monkeypox virus to enhance the immune responses using molecular screening and free energy calculations

  2024cites this paper
• Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system

  2024cites this paper
• Peptide-drug conjugates: A new paradigm for targeted cancer therapy.

  2024cites this paper
• Biological Evaluation of 3-Aryl and/or 4-(N-Aryl)aminocoumarins Against Human Pathogens: Antileishmanial and Antiviral Activities

  2024cites this paper
• Identification and assessment of the 1,6-dihydroxy-pyridin-2-one moiety as privileged scaffold for HBV ribonuclease H inhibition.

  2024cites this paper
• Identification of potential methyltransferase NSD2 enzymatic inhibitors through a multi-step structure-based drug design

  2024cites this paper
• Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response

  2024cites this paper
• Discovery of PLD4 modulators by high-throughput screening and kinetic analysis.

  2024cites this paper
• AI Promoted Virtual Screening, Structure-Based Hit Optimization, and Synthesis of Novel COVID-19 S-RBD Domain Inhibitors

  2024cites this paper
• Antitrypanosomal Potential of Chalcone‐Based Ursolic Acid Derivatives via Ligand‐Based Virtual Screening, DMPK Analyses, Molecular Dynamics Simulation, and MM/GBSA Binding Energy

  2024cites this paper
• Computational investigation of Pluchea indica mechanism targeting peroxisome proliferator-activated receptor gamma

  2024cites this paper
• The hypoglycemic potential of Syzygium cordatum (Hochst. ex Krauss.) extracts; in vitro analysis and in silico modelling

  2024cites this paper
• Exploring Marine-Derived Compounds: In Silico Discovery of Selective Ketohexokinase (KHK) Inhibitors for Metabolic Disease Therapy

  2024cites this paper
• A comprehensive review of artificial intelligence for pharmacology research

  2024cites this paper
• A Facile Synthesis of 3-Substituted Coumarins and Investigation of Their 3CLpro Inhibition Activity Against SARS-CoV-2.

  2024cites this paper
• A First-in-Class Pyrazole-isoxazole Enhanced Antifungal Activity of Voriconazole: Synergy Studies in an Azole-Resistant Candida albicans Strain, Computational Investigation and in Vivo Validation in a Galleria mellonella Fungal Infection Model.

  2024cites this paper
• Active Targets and Potential Mechanisms of Erhuang Quzhi Formula in Treating NAFLD: Network Analysis and Experimental Assessment

  2024cites this paper
• Synthetic Naphthoquinone Inhibits Herpes Simplex Virus Type-1 Replication Targeting Na+, K+ ATPase

  2024cites this paper
• In Silico and in Vitro Analysis of Pyrazolone Derivatives against Zika Virus and Identification of Potential NS5 Methyltransferase Inhibitors by Molecular Docking

  2024cites this paper
• N, N'-disubstituted Ureas as Novel Antiplatelet Agents: Synthesis, Pharmacological Evaluation and In Silico Studies.

  2024cites this paper
• Improved Quantum Algorithm: A Crucial Stepping Stone in Quantum-Powered Drug Discovery

  2024cites this paper
• Computational assessment of the toxicological profiles of various chemicals to which humans are exposed. A review

  2024cites this paper
• Exploring the Inhibitory Efficacy of Resokaempferol and Tectochrysin on PI3Kα Protein by Combining DFT and Molecular Docking against Wild-Type and H1047R Mutant Forms

  2024cites this paper
• Medicinal Plant Databases: Analyzing Strengths, Weaknesses and Innovations for Future Improvements

  2024cites this paper
• Structure-based virtual screening to identify hypocholesterolemic phytochemicals as potent inhibitors of squalene synthase a potential target for hypercholesterolemia

  2024cites this paper
• The Artificial Intelligence-Driven Pharmaceutical Industry: A Paradigm Shift in Drug Discovery, Formulation Development, Manufacturing, Quality Control, and Post-Market Surveillance.

  2024cites this paper
• Targeting the Cyclin-Dependent Kinase Family in Anticancer Drug Discovery: From Computational to Experimental Studies

  2024cites this paper
• New approaches in developing medicinal herbs databases

  2023cites this paper
• Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach

  2023cites this paper
• Inhibition of Neutral Sphingomyelinase 2 by Novel Small Molecule Inhibitors Results in Decreased Release of Extracellular Vesicles by Vascular Smooth Muscle Cells and Attenuated Calcification

  2023cites this paper
• AMALPHI: A Machine Learning Platform for Predicting Drug-Induced PhospholIpidosis

  2023cites this paper
• Integrated Network Pharmacology and Experimental Approach to Investigate the Protective Effect of Jin Gu Lian Capsule on Rheumatoid Arthritis by Inhibiting Inflammation via IL-17/NF-κB Pathway

  2023cites this paper
• ADMET and Solubility Analysis of New 5-Nitroisatine-Based Inhibitors of CDK2 Enzymes

  2023cites this paper
• Structure-based virtual screening and in vitro validation of inhibitors of cyclic dinucleotide phosphodiesterases ENPP1 and CdnP

  2023cites this paper
• Erlotinib-containing benzenesulfonamides as anti-Helicobacter pylori agents through carbonic anhydrase inhibition.

  2023cites this paper
• Identification of novel metallo-β-lactamases inhibitors using ligand-based pharmacophore modelling and structure-based virtual screening

  2023cites this paper
• Molecular docking analysis of PPARγ with phytochemicals from Moroccan medicinal plants

  2023cites this paper
• Therapeutic Potential of the Genus Zanthoxylum Phytochemicals: A Theoretical ADME/Tox Analysis.

  2023cites this paper
• Design, Synthesis, Anticancer and Antimicrobial Studies of 2‐Phenylthiazolidin‐4‐one Glycinamide Conjugates

  2023cites this paper
• Improving on in-silico prediction of oral drug bioavailability

  2023cites this paper
• Tools to enable the study and translation of supramolecular amphiphiles.

  2023cites this paper
• Revolutionizing Pharmaceutical Industry: The Radical Impact of Artificial Intelligence and Machine Learning.

  2023cites this paper
• Discovery of Potential Prolyl-tRNA Synthetase Allosteric Inhibitor Through Virtual Screening and In Vitro Assay against Plasmodium falciparum

  2023cites this paper
• Characterization of allosteric modulators that disrupt androgen receptor co-activator protein-protein interactions to alter transactivation–Drug leads for metastatic castration resistant prostate cancer

  2023cites this paper
• pBRICS: A Novel Fragmentation Method for Explainable Property Prediction of Drug-Like Small Molecules

  2023cites this paper
• Artificial intelligence in small molecule drug discovery from 2018 to 2023: Does it really work?

  2023cites this paper
• Exploring the natural products chemical space through a molecular search to discover potential inhibitors that target the hypoxia-inducible factor (HIF) prolyl hydroxylase domain (PHD)

  2023cites this paper
• Quinolinetrione-tacrine hybrids as multi-target-directed ligands against Alzheimer's disease.

  2023cites this paper
• Design and Diversity Analysis of Chemical Libraries in Drug Discovery.

  2023cites this paper